BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 10377788)

  • 1. [Campylobacter jejuni enteritis and Guillain-Barré syndrome].
    Yuki N
    Rinsho Shinkeigaku; 1999 Jan; 39(1):17-8. PubMed ID: 10377788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pathogenesis of Guillain-Barré syndrome and Fisher's syndrome: molecular mimicry between antecedent infectious agents and components of nerve tissues].
    Yuki N
    Rinsho Shinkeigaku; 1995 Dec; 35(12):1373-5. PubMed ID: 8752400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Guillain-Barré syndrome].
    Yuki N
    Nihon Rinsho; 1994 Nov; 52(11):2952-8. PubMed ID: 7996693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-GM1 IgG antibodies and Campylobacter bacteria in Guillain-Barré syndrome: evidence of molecular mimicry.
    Oomes PG; Jacobs BC; Hazenberg MP; Bänffer JR; van der Meché FG
    Ann Neurol; 1995 Aug; 38(2):170-5. PubMed ID: 7654064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Guillain-Barré syndrome of axonal type, Campylobacter jejuni infection and anti-ganglioside GM1 antibodies].
    Attarian S; Bonnefoi-Kyriacou B; Gayraud D; Mignard P; Boucraut J; Pouget J; Viallet F
    Rev Neurol (Paris); 1997 Apr; 153(3):205-8. PubMed ID: 9296136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GM1 antibody in Guillain-Barre syndrome after Campylobacter jejuni infection.
    Tang J; Yuan J; Hao H
    Chin Med J (Engl); 1995 Apr; 108(4):262-4. PubMed ID: 7789212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reactivity of serum IgG anti-GM1 ganglioside antibodies with the lipopolysaccharide fractions of Campylobacter jejuni isolates from patients with Guillain-Barre syndrome (GBS).
    Gregson NA; Rees JH; Hughes RA
    J Neuroimmunol; 1997 Mar; 73(1-2):28-36. PubMed ID: 9058756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Campylobacter jejuni infections and anti-GM1 antibodies in Guillain-Barré syndrome.
    Jacobs BC; van Doorn PA; Schmitz PI; Tio-Gillen AP; Herbrink P; Visser LH; Hooijkass H; van der Meché FG
    Ann Neurol; 1996 Aug; 40(2):181-7. PubMed ID: 8773599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Guillain-Barré syndrome associated with anti-GalNAc-GD1a antibody subsequent to Campylobacter jejuni enteritis].
    Tsuda N; Negoro K; Morimatsu M; Saito K; Yuki N
    Rinsho Shinkeigaku; 1995 Feb; 35(2):208-10. PubMed ID: 7781242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subclass of IgG antibody to GM1 epitope-bearing lipopolysaccharide of Campylobacter jejuni in patients with Guillain-Barré syndrome.
    Yuki N; Ichihashi Y; Taki T
    J Neuroimmunol; 1995 Jul; 60(1-2):161-4. PubMed ID: 7543907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A bacterium lipopolysaccharide that elicits Guillain-Barré syndrome has a GM1 ganglioside-like structure.
    Yuki N; Taki T; Inagaki F; Kasama T; Takahashi M; Saito K; Handa S; Miyatake T
    J Exp Med; 1993 Nov; 178(5):1771-5. PubMed ID: 8228822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathogenesis of axonal Guillain-Barré syndrome: hypothesis.
    Yuki N
    Muscle Nerve; 1994 Jun; 17(6):680-2. PubMed ID: 8196713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody to GalNAc-GD1a and GalNAc-GM1b in Guillain-Barré syndrome subsequent to Campylobacter jejuni enteritis.
    Yuki N; Taki T; Handa S
    J Neuroimmunol; 1996 Dec; 71(1-2):155-61. PubMed ID: 8982115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GM 1 antibodies in Guillain-Barré syndrome: isotypes, course and clinical outcome.
    Seiser A; Pötzl G; Safoschnik G; Pichler S; Bernheimer H; Schwerer B
    Wien Klin Wochenschr; 1994; 106(6):159-63. PubMed ID: 8197746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of Campylobacter jejuni serotype with antiganglioside antibody in Guillain-Barré syndrome and Fisher's syndrome.
    Yuki N; Takahashi M; Tagawa Y; Kashiwase K; Tadokoro K; Saito K
    Ann Neurol; 1997 Jul; 42(1):28-33. PubMed ID: 9225682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A patient with Guillain-Barré syndrome in association with Campylobacter jejuni enteritis (PEN19:LIO7) in a patient with HLA-B52 antigen].
    Kaida K; Yuki N; Takahashi M; Kamakura K; Nagata N
    Rinsho Shinkeigaku; 1994 Jul; 34(7):733-5. PubMed ID: 7955736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Guillain-Barré syndrome and infection].
    Saida T; Hao Q; Obayashi H; Nishimura K; Ozawa K; Saida K
    Rinsho Shinkeigaku; 1995 Dec; 35(12):1378-9. PubMed ID: 8752403
    [No Abstract]   [Full Text] [Related]  

  • 18. [Axonal Guillain-Barré syndrome associated with anti-GalNAc-GD1a antibody subsequent to Campylobacter jejuni (PEN 43) enteritis].
    Ihara Y; Saito K; Yoshimoto S; Hayabara T; Yuki N
    Rinsho Shinkeigaku; 1995 Aug; 35(8):901-3. PubMed ID: 8665735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibodies to gangliosides in Guillain-Barré syndrome: specificity and relationship to clinical features.
    Gregson NA; Koblar S; Hughes RA
    Q J Med; 1993 Feb; 86(2):111-7. PubMed ID: 8464986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The clinical correlates of high-titer IgG anti-GM1 antibodies.
    Kornberg AJ; Pestronk A; Bieser K; Ho TW; McKhann GM; Wu HS; Jiang Z
    Ann Neurol; 1994 Feb; 35(2):234-7. PubMed ID: 8109905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.